Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-1 Duration in Adjuvant Gastric Cancer
NCT02736552Phase 3Withdrawn
- Sponsor
- Fudan University
- Start
- Mar 2016
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tegafur in gastric cancer (GC), sponsored by Fudan University. Planned start Mar 2016; status: withdrawn.
02
Drugs
tegafur
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT02736552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02736552.